Pfizer
PFE
#134
Rank
ยฃ106.99 B
Marketcap
ยฃ18.82
Share price
0.60%
Change (1 day)
-3.74%
Change (1 year)

Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.

Market capitalization of Pfizer (PFE)

Market cap: ยฃ106.99 Billion

As of December 2025 Pfizer has a market cap of ยฃ106.99 Billion. This makes Pfizer the world's 134th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pfizer from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ106.99 B-10.99%
2024ยฃ120.21 B-5.79%
2023ยฃ127.59 B-46.33%
2022ยฃ237.74 B-3.17%
2021ยฃ245.54 B63.58%
2020ยฃ150.10 B-9.22%
2019ยฃ165.34 B-15.89%
2018ยฃ196.59 B23.07%
2017ยฃ159.74 B0.01%
2016ยฃ159.73 B18.76%
2015ยฃ134.50 B6.86%
2014ยฃ125.86 B5.93%
2013ยฃ118.82 B5.25%
2012ยฃ112.89 B5.49%
2011ยฃ107.02 B17.77%
2010ยฃ90.87 B0.18%
2009ยฃ90.71 B11.33%
2008ยฃ81.47 B5.33%
2007ยฃ77.35 B-17.88%
2006ยฃ94.19 B-5.37%
2005ยฃ99.54 B-4.9%
2004ยฃ104.67 B-30.53%
2003ยฃ150.67 B28.25%
2002ยฃ117.48 B-31.9%
2001ยฃ172.52 B-11.35%
2000ยฃ194.60 B151.98%
1999ยฃ77.22 B-20.61%
1998ยฃ97.27 B65.62%
1997ยฃ58.73 B87.87%
1996ยฃ31.26 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Pfizer was reported to be:

ยฃ106.40 Billion
by Nasdaq info icon info icon
ยฃ106.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
ยฃ188.63 B 76.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ371.45 B 247.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ82.41 B-22.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ717.57 B 570.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ195.04 B 82.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
ยฃ74.03 B-30.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
ยฃ131.70 B 23.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ163.11 B 52.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ211.62 B 97.78%๐Ÿ‡ฌ๐Ÿ‡ง UK